Table 1.

Clinical and Laboratory Characteristics of Pediatric ALL at Diagnosis or before Induction Phase Chemotherapy based on Survival and Death Outcomes

Age group	Outcome		P
	Alive	Died
	N=11 (%)	N=6 (%)
Age
1-10 years old	9 (81.8)	5 (83.3)	1.000a
>10 years old	2 (18.2)	1 (16.7)
Boys	9 (81.8)	6 (100)	0.515a
Hepatomegaly	8 (72.7)	5 (83.3)	1.000b
Splenomegaly	2 (18.2)	4 (66.7)	0.109b
Lymphadenopathy	1 (9.1)	3 (50)	0.099b
Hemoglobin levels
Hb < 8 g/dl	3 (27.3)	4 (66.7)	0.162a
Hb >8 g/dL	8 (72.7)	2 (33.3)
Trombocyte count
<150 x103/µL	6 (54.5)	6 (100)	0.102a
>150 x103/µL	5 (45.5)	0
Leukocyte count
<4 x103/µL	5 (45.4)	2 (33.3)	1.000c
4-20 x103/µL	3 (27.3)	2 (33.3)
>20 x103/µL	3 (27.3)	2 (33.3)
Neutrophil count
<500/µL	5 (45.5)	5 (83.3)	0.304b
>500/µL	6 (54.5)	1 (16.7)

^a, Fisher exact test; ^b, Chi-square test; ^c, Kplmogorof-Smirnov Z test